ArticleFrontiers in pharmacology2021

Nanomedicines and Nanosimilars-Why a Robust Centralised Regulatory Framework Is Essential to Enhance Patient Safety.

Michael P IslesPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.